Fmoc-L-serine

Fmoc-L-serine is an N-(9H-fluoren-9-ylmethoxycarbonyl)-protected L-serine amino acid in which the α-amino group is carbamate-protected by the Fmoc group while the side chain retains a primary hydroxymethyl functionality. The molecule presents a stereogenic center at the α-carbon with the L-configuration, along with a carboxylic acid suitable for peptide bond formation after activation. The Fmoc carbamate is base-labile under standard peptide-synthesis conditions, enabling iterative N-terminal deprotection and coupling without disturbing the serine hydroxyl. The presence of the unprotected side-chain alcohol provides a chemically reactive handle for orthogonal protection, derivatization, and downstream functionalization in peptide and peptidomimetic workflows.

1. Peptide Synthesis

Fmoc-L-serine is used as an Fmoc-protected serine building block for solid-phase peptide synthesis and related protected amino acid chemistry. The Fmoc carbamate protects the α-amine for controlled N-terminal deprotection, while the carboxylic acid participates in amide bond formation during peptide coupling cycles. The free side-chain hydroxyl can be selectively protected with orthogonal groups when required to prevent side reactions during chain assembly, then reintroduced or transformed after peptide elongation. Serine incorporation supports the construction of peptide backbones containing hydroxyl-bearing residues for subsequent phosphorylation-mimic design, crosslinking, or conjugation steps. Fmoc-L-serine therefore functions as a stereochemically defined, peptide-compatible intermediate for generating sequence-defined peptides and peptide analogs.

2. Side-Chain Functionalization

Fmoc-L-serine enables side-chain functionalization strategies in synthetic organic chemistry where the serine hydroxymethyl group serves as a primary alcohol for controlled derivatization. The protected α-amine and Fmoc group allow selective manipulation of the side chain through hydroxyl-reactive chemistry, including ether formation, esterification, and conversion to activated leaving-group derivatives for subsequent coupling. Orthogonal protection of the hydroxyl can be employed when preparing longer peptide sequences or when performing chemoselective modifications on complex scaffolds. Side-chain derivatization supports the synthesis of functionalized amino acid derivatives used in peptidomimetic construction, affinity probes, and chemical biology reagents. Fmoc-L-serine thus provides a chiral, protected amino acid platform for generating downstream molecules with defined stereochemistry and functional group placement.

3. Chemical Biology Probes

Fmoc-L-serine is applied in chemical biology workflows that require hydroxyl-bearing amino acid residues for labeling, probe construction, and biomolecular modification chemistries. The serine side-chain alcohol can be engineered into clickable handles, linker arms, or reactive intermediates while the Fmoc-protected backbone supports incorporation into peptide tags and sequence-defined capture reagents. Base-labile Fmoc chemistry supports iterative assembly of peptide-based probes, and orthogonal side-chain protection can be used to maintain functional group integrity during synthesis. The resulting serine-containing constructs can serve as substrates or recognition elements in biochemical assays where hydroxyl functionality influences binding or reactivity. Fmoc-L-serine therefore supports the preparation of research-grade peptide materials that integrate chiral amino acid stereochemistry with chemically addressable side-chain functionality.

4. Peptidomimetics And SAR Studies

Fmoc-L-serine is suitable for peptidomimetic construction and structure-activity relationship studies where controlled incorporation of serine-like hydroxymethyl motifs is required. The L-configuration at the α-carbon provides stereochemical definition that can be preserved through peptide analog synthesis, while the carboxy and Fmoc-protected amine enable systematic assembly of analog series by peptide coupling chemistry. Side-chain hydroxyl functionality can be retained, protected, or transformed into conformationally restricted mimics, enabling SAR-driven exploration of hydrogen-bonding and polarity effects. Fmoc-L-serine-derived intermediates can also be used to generate fragment libraries for medicinal chemistry research, including hydroxyl-functional scaffolds for binding-site probing. Fmoc-L-serine thus supports rational design workflows linking amino acid derivatization to downstream molecular scaffold generation.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-serine is used in pharmaceutical intermediate preparation and process-oriented fine chemical synthesis where protected amino acid building blocks are required for controlled assembly of peptide-like fragments. The Fmoc carbamate provides a robust, isolable N-protection strategy compatible with iterative coupling and subsequent deprotection, supporting scalable routes to serine-containing intermediates. The free hydroxymethyl group can be orthogonally protected to manage chemoselectivity during multi-step manufacturing sequences, then deprotected or converted to desired functional forms for downstream synthesis. The defined L-stereochemistry at the α-carbon supports consistent stereochemical outcomes in chiral intermediate manufacture. Fmoc-L-serine therefore serves as a practical chiral amino acid intermediate for producing serine-bearing peptide fragments, peptidomimetic building blocks, and related functional organics used in applied product development.

1. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

2. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics